A detailed history of Mach 1 Financial Group, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Mach 1 Financial Group, LLC holds 2,280 shares of JNJ stock, worth $332,538. This represents 0.26% of its overall portfolio holdings.

Number of Shares
2,280
Previous 2,512 9.24%
Holding current value
$332,538
Previous $367,000 0.54%
% of portfolio
0.26%
Previous 0.29%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$145.48 - $167.38 $33,751 - $38,832
-232 Reduced 9.24%
2,280 $369,000
Q2 2024

Jul 30, 2024

BUY
$144.38 - $157.78 $82,152 - $89,776
569 Added 29.28%
2,512 $367,000
Q1 2024

May 10, 2024

SELL
$155.22 - $162.74 $847,345 - $888,397
-5,459 Reduced 73.75%
1,943 $307,000
Q4 2023

Feb 05, 2024

SELL
$145.6 - $158.88 $938,683 - $1.02 Million
-6,447 Reduced 46.55%
7,402 $1.16 Million
Q3 2023

Oct 17, 2023

BUY
$155.75 - $174.48 $3,270 - $3,664
21 Added 0.15%
13,849 $2.16 Million
Q2 2023

Jul 28, 2023

BUY
$154.35 - $166.11 $1.88 Million - $2.03 Million
12,196 Added 747.3%
13,828 $2.29 Million
Q1 2023

May 10, 2023

SELL
$151.05 - $180.26 $755,703 - $901,840
-5,003 Reduced 75.4%
1,632 $252,000
Q4 2022

Feb 02, 2023

BUY
$160.2 - $179.79 $799,878 - $897,691
4,993 Added 304.08%
6,635 $1.17 Million
Q3 2022

Nov 08, 2022

SELL
$161.33 - $179.52 $17,423 - $19,388
-108 Reduced 6.17%
1,642 $267,000
Q2 2022

Aug 04, 2022

BUY
$168.19 - $186.01 $252,789 - $279,573
1,503 Added 608.5%
1,750 $309,000
Q1 2022

May 06, 2022

SELL
$158.14 - $179.59 $3,953 - $4,489
-25 Reduced 9.19%
247 $43,000
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $42,412 - $47,058
272 New
272 $46,000
Q3 2021

Oct 18, 2021

SELL
$161.5 - $179.47 $39,890 - $44,329
-247 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $37,808 - $42,108
247 New
247 $40,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mach 1 Financial Group, LLC Portfolio

Follow Mach 1 Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mach 1 Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mach 1 Financial Group, LLC with notifications on news.